Somatic mutations in these genes were detected in 537 of 1284 (41.8 %) primary tumours: 457 (35.6 %) KRAS, 53 (4.1 %) NRAS, and 27 (2.1 %) BRAF mutations. The gene discussed is NRAS; the disease is neoplasm.